Azizi Ray, Ph.D., is a post-doctoral fellow supported by the NIDA T32 program at the University of Arkansas for Medical Sciences. Dr. Ray’s broad research interests include implementing pharmacists-led interventions to mitigate overdose deaths in African American justice-involved populations with OUD and reduce racial/ethnic disparities in mental health care. Dr. Ray’s additional goal is to increase access to MOUD to vulnerable populations most at risk for overdose by expanding the practice of pharmacists who are often under-utilized as healthcare providers. Dr. Ray’s preclinical experiences are varied and span pharmacology, neurobiology, and treatments for substance abuse disorders with an emphasis on overdose deaths, neurotoxicity, and the abuse liability of traditional stimulants of abuse and synthetic cathinones.